References
- Cole SL, Kaye H, Griffith GC: Assay of anti-anginal agents. I. A curve analysis with multiple control periods. Circulation 15: 405–413, 1957
- Aronow WS, Chesluk HM: Sublingual isosorbide dinitrate therapy versus sublingual placebo in angina pectoris. Circulation 41: 869–874, 1970
- Harding PR, Aronow WS, Eisenman J: Digitalis as an antianginal agent. Chest 64: 439–443, 1973
- Wasserman AJ, Proctor JD, Allen FJ, et al: Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: Hemodynamic, antiarrhythmic, and antianginal. J Clin Pharmacol 10: 37–49, 1970
- Aronow WS: Use of nitrates as antianginal agents. In Needleman P (Editor): Handbook of Experimental Pharmacology. New York, Springer-Verlag New York, Inc, 1975, pp 163–174
- Goldstein RE, Rosing DR, Redwood DR, et al: Clinical and circulatory effects of isosorbide dinitrate: Comparison with nitroglycerin. Circulation 43: 629–640, 1971
- Klaus AP, Zaret BL, Pitt BL, et al: Comparative evaluation of sublingual long-acting nitrates. Circulation 48: 519–525, 1973
- Caracta AR, Ogunkelu JB, Lau SH, et al: Comparative effects of sublingual pentaerythritol trinitrate and nitroglycerin in angina pectoris during treadmill exercise. Circulation 50 (Suppl 3): 218, 1974
- Ganz W, Marcus HS: Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation 46: 880–889, 1972
- Needleman P, Lang S, Johnson EM Jr: Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181: 489–497, 1972
- Freis ED, Gaffney TE, Kirkendall W, et al: Report of the panels on cardiovascular drugs from the drug efficacy study: Statement on criteria for evaluation of long-acting coronary vasodilators in treatment of angina pectoris. Circulation 41: 149–151, 1970
- Modell W: Clinical pharmacology of antianginal drugs. Clin Pharmacol Ther 3: 97–108, 1962
- Lange RL, Reid MS, Tresch DD, et al: Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 46: 666–678, 1972
- Reichek N, Goldstein RE, Redwood DR, et al: Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation 50: 348–352, 1974
- Aronow WS: The medical treatment of angina pectoris. VI. Propranolol as an antianginal drug. Am Heart J 84: 706–709, 1972
- Aronow WS, Kaplan MA: Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris. N Engl J Med 280: 847–850, 1969
- Miller RR, Olson HG, Amsterdam EA, et al: Propranolol-withdrawal rebound phenomenon: Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 293: 416–418, 1975
- Aronow WS: The medical treatment of angina pectoris. VII. Newer beta-adrenergic blockers as antianginal drugs. Am Heart J 84: 834–837, 1972
- Mitchell JH, Vastagh GF, Cohen LS: Inotropic and chronotropic responses to newer beta-adrenergic blocking agents. Circulation 42 (Suppl 3): 123, 1970
- Burgin D: [Hemodynamic changes following beta- receptor blockade in healthy subjects and patients with coronary heart disease]. Schweiz Med Wochenschr 98: 940–945, 1968 (Ger)
- Goldstein RE, Hall CA, Epstein SE: Comparison of relative inotropic and chronotropic effects of propranolol, practolol, and Sotalol. Chest 64: 619–627, 1973
- Aronow WS, Spivack N, Laverty W, et al: Effect of tolamolol and propranolol on exercise heart rate and angina. Clin Pharmacol Ther 17: 379–384, 1975
- Aronow WS, March H, Vangrow JS, et al: Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina. Br Heart J 36: 1078–1081, 1974
- Aronow WS: Medical treatment of angina pectoris. VIII. Miscellaneous antianginal drugs. Am Heart J 85: 132–137, 1973